Managing Neuro Emergencies: Faculty Disclosure and Financial Support

This presentation focuses on neuro emergencies with insights from faculty disclosure of financial relationships with sponsors and organizations. It also highlights financial support received and the mitigation of potential bias in the content.

• Neuro emergencies
• Faculty disclosure
• Financial support
• Potential bias
• Medical education

emme Follow

Uploaded on Jul 29, 2024 | 0 Views

Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

Presentation Transcript

1. CAEP23 NEURO EMERGENCIES

2. Faculty/Presenter Disclosure Faculty: [Speaker s name] Relationships with financial sponsors: Any direct financial relationships including receipt of honoraria: PharmaCorpABC, Canadian Cancer Org. Memberships on advisory boards or speakers bureau: XYZ Biopharmaceuticals Ltd. Patents for drugs or devices: Widget ABC Other: financial relationships/investments: Employee of XXY Hospital Group, consultant for Company X

3. Disclosure of Financial Support This program has received financial support from [organization name] in the form of [describe support here e.g. an educational grant]. This program has received in-kind support from [organization name] in the form of [describe support here e.g. logistical support]. Potential for conflict(s) of interest: [Speaker/Faculty name] has received [payment/funding, etc.] from [organization supporting this program AND/OR organization whose product(s) are being discussed in this program]. [Supporting organization name] [developed/licenses/distributes/benefits from the sale of, etc.] a product that will be discussed in this program: [insert generic and brand name here].

4. Mitigating Potential Bias [Explain how potential sources of bias identified in slides 1 and 2 have been mitigated by the scientific planning committee]. Refer to Quick Tips document for information on how this can be done

5. Title Sales 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr

6. Title Bullet 1 Sub-bullet

7. Title Text

8. Sample Quote -XXXX

9. Title Sample Test Step 2 Step 3 Step 1

10. Thank you